Company intelligence / Profile preview

NovaQuest Capital Management

Raleigh, North Carolina, United Statesnovaquest.com ↗
Ownership
Private
Employees
~75
Development stage
Other
01

Overview

As an investment firm rather than a drug developer, NovaQuest does not have clinical results. Its investments enable late-stage clinical trials and commercialization for partner biopharma firms.

Therapeutic areas
ImmunologyRare DiseasesOtherRheumatologyNeurology
Modalities
Not directly applicableSmall moleculeMonoclonal antibodyAntibody-drug conjugateGene therapyEnzyme replacement therapyBiologicEnzyme-based biologic
Industry
Investors
02

Partnerships

Bain Capital (co-investment in Cerevel Therapeutics)FibroGenGrünenthalHansa Biopharma

Beyond the preview

Go deeper on NovaQuest Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovaQuest Capital Management.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call